Sysmex Corp (6869) - Product Pipeline Analysis, 2023 Update

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $750	75 Pages	GlobalData	July, 2023	GBDT18100616

Best Price Guarantee
Price	from $750
Length	75 Pages
Publisher	GlobalData
Published Date	July, 2023
SKU	GBDT18100616

North America Anime Market Summary, Competitive Analysis and Forecast to 2027

Summary

Anime in North America industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2017-22, and forecast to 2027). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Highlights

Anime is a kind of animation that first originated in Japan and is distinguished by action-packed stories with vivid characters that typically have fantastical or futuristic themes. These anime are accessible through various forms such as TV, movie, video, internet distribution, merchandising, music, and live entertainment.
The North American anime market had total revenues of $9.2 billion in 2022, representing a compound annual growth rate (CAGR) of 5.7% between 2017 and 2022.
The merchandising segment accounted for market's the largest proportion in 2022, with total revenues of $1.9 billion, equivalent to 20.6% of the market's overall value.
The widespread ownership of smartphones has greatly contributed to the accessibility of anime and the increase in internet services has resulted in moderate growth of the North American anime market in 2022.

Scope

Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the anime market in North America
Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the anime market in North America
Leading company profiles reveal details of key anime market players’ global operations and financial performance
Add weight to presentations and pitches by understanding the future growth prospects of the North America anime market with five year forecasts

Reasons to Buy

What was the size of the North America anime market by value in 2022?
What will be the size of the North America anime market in 2027?
What factors are affecting the strength of competition in the North America anime market?
How has the market performed over the last five years?
Who are the top competitors in North America's anime market?

Sysmex Corp Company Overview: Sysmex Corp Company Snapshot; Sysmex Corp Pipeline Products and Ongoing Clinical Trials Overview; Sysmex Corp – Pipeline Analysis Overview; Business Description; Sysmex Corp - Key Facts; Sysmex Corp - Major Products and Services; Sysmex Corp Pipeline Products by Development Stage; Sysmex Corp Pipeline Products Overview; Antigen Saliva Test - COVID-19; Antigen Saliva Test - COVID-19 Product Overview; Antigen Test - COVID-19; Antigen Test - COVID-19 Product Overview; Automated Hematology Analyzer XN-31; Automated Hematology Analyzer XN-31 Product Overview; Blood-based Diagnostic Assay - Cancer; Blood-based Diagnostic Assay - Cancer Product Overview; Cancer Diagnostic Reagent; Cancer Diagnostic Reagent Product Overview; Cancer Related Gene Panel Test System; Cancer Related Gene Panel Test System Product Overview; Captiver System; Captiver System Product Overview; Companion Diagnostic DNA Test; Companion Diagnostic DNA Test Product Overview; Diagnostic Assay - Colorectal Cancer; Diagnostic Assay - Colorectal Cancer Product Overview; Diagnostic Test - Atopic Dermatitis; Diagnostic Test - Atopic Dermatitis Product Overview; Diagnostic Test - Liver Fibrosis; Diagnostic Test - Liver Fibrosis Product Overview; Diagnostic Test - Pancreatic Cancer; Diagnostic Test - Pancreatic Cancer Product Overview; Immuno-flowFISH - Bone Marrow Cancer; Immuno-flowFISH - Bone Marrow Cancer Product Overview; Immuno-flowFISH Test - Leukaemia; Immuno-flowFISH Test - Leukaemia Product Overview; Immunochemistry Test - Bile Duct Cancer; Immunochemistry Test - Bile Duct Cancer Product Overview; Immunochemistry Test - CK19F; Immunochemistry Test - CK19F Product Overview; Immunochemistry Test - FSH; Immunochemistry Test - FSH Product Overview; Immunochemistry Test - HAV Ab; Immunochemistry Test - HAV Ab Product Overview; Immunochemistry Test - HBc IgM; Immunochemistry Test - HBc IgM Product Overview; Immunochemistry Test - LH; Immunochemistry Test - LH Product Overview; Immunochemistry Test - Tg Ab; Immunochemistry Test - Tg Ab Product Overview; Immunochemistry Test - TPO Ab; Immunochemistry Test - TPO Ab Product Overview; Immunochemistry Test - TR Ab; Immunochemistry Test - TR Ab Product Overview; Inherited Retinal Dystrophy Gene Panel Test System; Inherited Retinal Dystrophy Gene Panel Test System Product Overview; Liquid Biopsy System; Liquid Biopsy System Product Overview; Minimally Invasive Postprandial Hyperglycemia Monitoring System; Minimally Invasive Postprandial Hyperglycemia Monitoring System Product Overview; Multiplex Gene Panel Test; Multiplex Gene Panel Test Product Overview; Next Generation Sequencing Based Companion Diagnostic Assay; Next Generation Sequencing Based Companion Diagnostic Assay Product Overview; Next-Generation Diagnostic Reagent - Dementia; Next-Generation Diagnostic Reagent - Dementia Product Overview; NGS Analysis Software; NGS Analysis Software Product Overview; Non-Invasive Prenatal Test - Down's Syndrome; Non-Invasive Prenatal Test - Down's Syndrome Product Overview; OGT SLE Test; OGT SLE Test Product Overview; OncoBEAM - Hepatocellular Carcinoma; OncoBEAM - Hepatocellular Carcinoma Product Overview; OncoBEAM - Pancreatic Cancer; OncoBEAM - Pancreatic Cancer Product Overview; PA-100 Analyser With PA AST Panel U-0501; PA-100 Analyser With PA AST Panel U-0501 Product Overview; Protein Biomarker Assay - Prostate Cancer; Protein Biomarker Assay - Prostate Cancer Product Overview; Screening System - Cervical Cancer; Screening System - Cervical Cancer Product Overview; Sysmex XQ-320 Automated Hematology Analyzer; Sysmex XQ-320 Automated Hematology Analyzer Product Overview; Sysmex XS-1000i AutoLoader Automated Hematology Analyzer - IG% Assay; Sysmex XS-1000i AutoLoader Automated Hematology Analyzer - IG% Assay Product Overview; Sysmex XS-1000i Automated Hematology Analyzer - IG% Assay; Sysmex XS-1000i Automated Hematology Analyzer - IG% Assay Product Overview; Sysmex Corp - Key Competitors; Sysmex Corp - Key Employees; Sysmex Corp - Key Employee Biographies; Sysmex Corp - Locations And Subsidiaries; Head Office; Other Locations & Subsidiaries; Joint Venture; Recent Developments; Sysmex Corp, Recent Developments; Apr 18, 2023: Juntendo University, Sysmex, and ThinkCyte collaborate to advance the early detection and treatment of blood cancer; Apr 17, 2023: Sysmex to establish new manufacturing base in India; Apr 13, 2023: Sysmex Inostics and Genomic Testing Cooperative form partnership to accelerate therapeutic discovery and development; Feb 14, 2023: Sysmex Inostics opens Cancer Research Excellence Program for submissions; Feb 09, 2023: Sysmex Announces Summary of Consolidated Financial Results for the First Nine Months of the Fiscal Year Ending March 31, 2023; Feb 08, 2023: Sysmex Corp. Notice of Changes in Representative Directors; Sep 08, 2022: Toho pharmaceutical and Sysmex to Commence dry ice-free supply of quality control reagents for clinical chemistry tests; Jul 01, 2022: Sysmex launches sample transportation system modules for XR Series of Automated Hematology Analyzer; Feb 10, 2022: Sysmex announces Summary of Consolidated Financial Results for the First Nine Months of the Fiscal Year Ending March 31, 2022; Nov 10, 2021: Sysmex Announcement Regarding Differences between Actual and Forecast Figures for the Six Months Ended September 30, 2021, and Revision of Full-Year Financial Forecasts; Appendix; Methodology; About GlobalData; Contact Us; Disclaimer
List of Tables: Table 1: Sysmex Corp Pipeline Products and Ongoing Clinical Trials Overview; Table 2: Sysmex Corp Pipeline Products by Equipment Type; Table 3: Sysmex Corp Pipeline Products by Indication; Table 4: Sysmex Corp, Key Facts; Table 5: Sysmex Corp, Major Products and Services; Table 6: Sysmex Corp Number of Pipeline Products by Development Stage; Table 7: Sysmex Corp Pipeline Products Summary by Development Stage; Table 8: Antigen Saliva Test - COVID-19 - Product Status; Table 9: Antigen Saliva Test - COVID-19 - Product Description; Table 10: Antigen Test - COVID-19 - Product Status; Table 11: Antigen Test - COVID-19 - Product Description; Table 12: Automated Hematology Analyzer XN-31 - Product Status; Table 13: Automated Hematology Analyzer XN-31 - Product Description; Table 14: Blood-based Diagnostic Assay - Cancer - Product Status; Table 15: Blood-based Diagnostic Assay - Cancer - Product Description; Table 16: Cancer Diagnostic Reagent - Product Status; Table 17: Cancer Diagnostic Reagent - Product Description; Table 18: Cancer Related Gene Panel Test System - Product Status; Table 19: Cancer Related Gene Panel Test System - Product Description; Table 20: Captiver System - Product Status; Table 21: Captiver System - Product Description; Table 22: Companion Diagnostic DNA Test - Product Status; Table 23: Companion Diagnostic DNA Test - Product Description; Table 24: Diagnostic Assay - Colorectal Cancer - Product Status; Table 25: Diagnostic Assay - Colorectal Cancer - Product Description; Table 26: Diagnostic Test - Atopic Dermatitis - Product Status; Table 27: Diagnostic Test - Atopic Dermatitis - Product Description; Table 28: Diagnostic Test - Liver Fibrosis - Product Status; Table 29: Diagnostic Test - Liver Fibrosis - Product Description; Table 30: Diagnostic Test - Pancreatic Cancer - Product Status; Table 31: Diagnostic Test - Pancreatic Cancer - Product Description; Table 32: Immuno-flowFISH - Bone Marrow Cancer - Product Status; Table 33: Immuno-flowFISH - Bone Marrow Cancer - Product Description; Table 34: Immuno-flowFISH Test - Leukaemia - Product Status; Table 35: Immuno-flowFISH Test - Leukaemia - Product Description; Table 36: Immunochemistry Test - Bile Duct Cancer - Product Status; Table 37: Immunochemistry Test - Bile Duct Cancer - Product Description; Table 38: Immunochemistry Test - CK19F - Product Status; Table 39: Immunochemistry Test - CK19F - Product Description; Table 40: Immunochemistry Test - FSH - Product Status; Table 41: Immunochemistry Test - FSH - Product Description; Table 42: Immunochemistry Test - HAV Ab - Product Status; Table 43: Immunochemistry Test - HAV Ab - Product Description; Table 44: Immunochemistry Test - HBc IgM - Product Status; Table 45: Immunochemistry Test - HBc IgM - Product Description; Table 46: Immunochemistry Test - LH - Product Status; Table 47: Immunochemistry Test - LH - Product Description; Table 48: Immunochemistry Test - Tg Ab - Product Status; Table 49: Immunochemistry Test - Tg Ab - Product Description; Table 50: Immunochemistry Test - TPO Ab - Product Status; Table 51: Immunochemistry Test - TPO Ab - Product Description; Table 52: Immunochemistry Test - TR Ab - Product Status; Table 53: Immunochemistry Test - TR Ab - Product Description; Table 54: Inherited Retinal Dystrophy Gene Panel Test System - Product Status; Table 55: Inherited Retinal Dystrophy Gene Panel Test System - Product Description; Table 56: Liquid Biopsy System - Product Status; Table 57: Liquid Biopsy System - Product Description; Table 58: Minimally Invasive Postprandial Hyperglycemia Monitoring System - Product Status; Table 59: Minimally Invasive Postprandial Hyperglycemia Monitoring System - Product Description; Table 60: Multiplex Gene Panel Test - Product Status; Table 61: Multiplex Gene Panel Test - Product Description; Table 62: Next Generation Sequencing Based Companion Diagnostic Assay - Product Status; Table 63: Next Generation Sequencing Based Companion Diagnostic Assay - Product Description; Table 64: Next-Generation Diagnostic Reagent - Dementia - Product Status; Table 65: Next-Generation Diagnostic Reagent - Dementia - Product Description; Table 66: NGS Analysis Software - Product Status; Table 67: NGS Analysis Software - Product Description; Table 68: Non-Invasive Prenatal Test - Down's Syndrome - Product Status; Table 69: Non-Invasive Prenatal Test - Down's Syndrome - Product Description; Table 70: OGT SLE Test - Product Status; Table 71: OGT SLE Test - Product Description; Table 72: OncoBEAM - Hepatocellular Carcinoma - Product Status; Table 73: OncoBEAM - Hepatocellular Carcinoma - Product Description; Table 74: OncoBEAM - Pancreatic Cancer - Product Status; Table 75: OncoBEAM - Pancreatic Cancer - Product Description; Table 76: PA-100 Analyser With PA AST Panel U-0501 - Product Status; Table 77: PA-100 Analyser With PA AST Panel U-0501 - Product Description; Table 78: Protein Biomarker Assay - Prostate Cancer - Product Status; Table 79: Protein Biomarker Assay - Prostate Cancer - Product Description; Table 80: Screening System - Cervical Cancer - Product Status; Table 81: Screening System - Cervical Cancer - Product Description; Table 82: Sysmex XQ-320 Automated Hematology Analyzer - Product Status; Table 83: Sysmex XQ-320 Automated Hematology Analyzer - Product Description; Table 84: Sysmex XS-1000i AutoLoader Automated Hematology Analyzer - IG% Assay - Product Status; Table 85: Sysmex XS-1000i AutoLoader Automated Hematology Analyzer - IG% Assay - Product Description; Table 86: Sysmex XS-1000i Automated Hematology Analyzer - IG% Assay - Product Status; Table 87: Sysmex XS-1000i Automated Hematology Analyzer - IG% Assay - Product Description; Table 88: Sysmex Corp, Key Employees; Table 89: Sysmex Corp, Key Employee Biographies; Table 90: Sysmex Corp, Other Locations; Table 91: Sysmex Corp, Subsidiaries; Table 92: Sysmex Corp, Joint Venture; Table 93: Glossary
List of Figures: Figure 1: Sysmex Corp Pipeline Products by Equipment Type; Figure 2: Sysmex Corp Pipeline Products by Development Stage